{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T12:31:25Z","timestamp":1682339485848},"reference-count":64,"publisher":"Japanese Society of Toxicology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2021]]},"DOI":"10.2131\/jts.46.131","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T22:12:32Z","timestamp":1614550352000},"page":"131-142","source":"Crossref","is-referenced-by-count":1,"title":["Human ES and iPS cells display less drug resistance than differentiated cells, and na\u00efve-state induction further decreases drug resistance"],"prefix":"10.2131","volume":"46","author":[{"given":"Yulia","family":"Panina","sequence":"first","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Yamane","sequence":"additional","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Sone","sequence":"additional","affiliation":[{"name":"Environmental Health and Prevention Research Unit, Yokohama University of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Fujibuchi","sequence":"additional","affiliation":[{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Adler, S., Pellizzer, C., Hareng, L., Hartung, T. and Bremer, S. (2008): First steps in establishing a developmental toxicity test method based on human embryonic stem cells. Toxicol. In Vitro, <b>22<\/b>, 200-211.","DOI":"10.1016\/j.tiv.2007.07.013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ambudkar, S.V., Dey, S., Hrycyna, C.A., Ramachandra, M., Pastan, I. and Gottesman, M.M. (1999): Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol., <b>39<\/b>, 361-398.","DOI":"10.1146\/annurev.pharmtox.39.1.361"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Athreya, B.H., Gorske, A.L. and Myers, A.R. (1973): Aspirin-induced abnormalities of liver function. Am. J. Dis. Child., <b>126<\/b>, 638-641.","DOI":"10.1001\/archpedi.1973.02110190510010"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Barone, R., Chase, P.H. and Wallace, S.L. (1976): Letter: salicylate-induced hepatic injury. Arthritis Rheum., <b>19<\/b>, 964-966.","DOI":"10.1002\/art.1780190529"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Betschinger, J., Nichols, J., Dietmann, S., Corrin, P.D., Paddison, P.J. and Smith, A. (2013): Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3. Cell, <b>153<\/b>, 335-347.","DOI":"10.1016\/j.cell.2013.03.012"},{"key":"6","first-page":"191","year":"2007","unstructured":"Brons, I.G., Smithers, L.E., Trotter, M.W., Rugg-Gunn, P., Sun, B., Chuva de Sousa Lopes, S.M., Howlett, S.K., Clarkson, A., Ahrlund-Richter, L., Pedersen, R.A. and Vallier, L. (2007): Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature, <b>448<\/b>, 191-195.","journal-title":"?Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Carter, M.G., Smagghe, B.J., Stewart, A.K., Rapley, J.A., Lynch, E., Bernier, K.J., Keating, K.W., Hatziioannou, V.M., Hartman, E.J. and Bamdad, C.C. (2016): A primitive growth factor, NME7AB, is sufficient to induce stable na\u00efve state human pluripotency; reprogramming in this novel growth factor confers superior differentiation. Stem Cells, <b>34<\/b>, 847-859.","DOI":"10.1002\/stem.2261"},{"key":"8","first-page":"663","year":"2013","unstructured":"Chan, Y.-S., G\u00f6ke, J., Ng, J.-H., Lu, X., Gonzales, K.A., Tan, C.-P., Tng, W.-Q., Hong, Z.-Z., Lim, Y.-S. and Ng, H.-H. (2013): Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. Cell Stem Cell, <b>13<\/b>, 663-675.","journal-title":"Cell Stem Cell","ISSN":"http:\/\/id.crossref.org\/issn\/1934-5909","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Chen, H., Aksoy, I., Gonnot, F., Osteil, P., Aubry, M., Hamela, C., Rognard, C., Hochard, A., Voisin, S., Fontaine, E., Mure, M., Afanassieff, M., Cleroux, E., Guibert, S., Chen, J., Vallot, C., Acloque, H., Genthon, C., Donnadieu, C., De Vos, J., Sanlaville, D., Gu\u00e9rin, J.F., Weber, M., Stanton, L.W., Rougeulle, C., Pain, B., Bourillot, P.Y. and Savatier, P. (2015): Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency. Nat. Commun., <b>6<\/b>, 7095.","DOI":"10.1038\/ncomms8095"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Chen, M., Suzuki, A., Thakkar, S., Yu, K., Hu, C. and Tong, W. (2016): DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov. Today, <b>21<\/b>, 648-653.","DOI":"10.1016\/j.drudis.2016.02.015"},{"key":"11","first-page":"911","year":"2016","unstructured":"Choi, H.W., Joo, J.Y., Hong, Y.J., Kim, J.S., Song, H., Lee, J.W., Wu, G., Sch\u00f6ler, H.R. and Do, J.T. (2016): Distinct enhancer activity of oct4 in naive and primed mouse pluripotency. Stem Cell Reports, <b>7<\/b>, 911-926.","journal-title":"Stem Cell Reports","ISSN":"http:\/\/id.crossref.org\/issn\/2213-6711","issn-type":"print"},{"key":"12","first-page":"5","year":"2012","unstructured":"Christodoulou, C. and Kotton, D.N. (2012): Are embryonic stem and induced pluripotent stem cells the same or different? Implications for their potential therapeutic use. Cell Cycle, <b>11<\/b>, 5-6.","journal-title":"Cell Cycle","ISSN":"http:\/\/id.crossref.org\/issn\/1538-4101","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Duggal, G., Warrier, S., Ghimire, S., Broekaert, D., Van der Jeught, M., Lierman, S., Deroo, T., Peelman, L., Van Soom, A., Cornelissen, R., Menten, B., Mestdagh, P., Vandesompele, J., Roost, M., Slieker, R.C., Heijmans, B.T., Deforce, D., De Sutter, P., De Sousa Lopes, S.C. and Heindryckx, B. (2015): Alternative routes to induce na\u00efve pluripotency in human embryonic stem cells. Stem Cells, <b>33<\/b>, 2686-2698.","DOI":"10.1002\/stem.2071"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Fukunaga-Kalabis, M. and Herlyn, M. (2012): Beyond ABC: another mechanism of drug resistance in melanoma side population. J. Invest. Dermatol., <b>132<\/b>, 2317-2319.","DOI":"10.1038\/jid.2012.220"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Gillet, J.-P. and Gottesman, M.M. (2010): Mechanisms of multidrug resistance in cancer. Methods Mol. Biol., <b>596<\/b>, 47-76.","DOI":"10.1007\/978-1-60761-416-6_4"},{"key":"16","unstructured":"Goldenberg, D.L. (1974): Letter: aspirin hepatotoxicity. Ann. Intern. Med., <b>80<\/b>, 773."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Gottesman, M.M., Fojo, T. and Bates, S.E. (2002): Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer, <b>2<\/b>, 48-58.","DOI":"10.1038\/nrc706"},{"key":"18","first-page":"215","year":"2010","unstructured":"Greber, B., Wu, G., Bernemann, C., Joo, J.Y., Han, D.W., Ko, K., Tapia, N., Sabour, D., Sterneckert, J., Tesar, P. and Sch\u00f6ler, H.R. (2010): Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell, <b>6<\/b>, 215-226.","journal-title":"Cell Stem Cell","ISSN":"http:\/\/id.crossref.org\/issn\/1934-5909","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Gu, Q., Hao, J., Zhao, X.Y., Li, W., Liu, L., Wang, L., Liu, Z.H. and Zhou, Q. (2012): Rapid conversion of human ESCs into mouse ESC-like pluripotent state by optimizing culture conditions. Protein Cell, <b>3<\/b>, 71-79.","DOI":"10.1007\/s13238-012-2007-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Hackett, C.H. and Fortier, L.A. (2011): Embryonic stem cells and iPS cells: sources and characteristics. Vet. Clin. North Am. Equine Pract., <b>27<\/b>, 233-242.","DOI":"10.1016\/j.cveq.2011.04.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Hanna, J., Cheng, A.W., Saha, K., Kim, J., Lengner, C.J., Soldner, F., Cassady, J.P., Muffat, J., Carey, B.W. and Jaenisch, R. (2010): Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl. Acad. Sci. USA, <b>107<\/b>, 9222-9227.","DOI":"10.1073\/pnas.1004584107"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Hotta, A., Cheung, A.Y., Farra, N., Garcha, K., Chang, W.Y., Pasceri, P., Stanford, W.L. and Ellis, J. (2009a): EOS lentiviral vector selection system for human induced pluripotent stem cells. Nat. Protoc., <b>4<\/b>, 1828-1844.","DOI":"10.1038\/nprot.2009.201"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Hotta, A., Cheung, A.Y., Farra, N., Vijayaragavan, K., S\u00e9guin, C.A., Draper, J.S., Pasceri, P., Maksakova, I.A., Mager, D.L., Rossant, J., Bhatia, M. and Ellis, J. (2009b): Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat. Methods, <b>6<\/b>, 370-376.","DOI":"10.1038\/nmeth.1325"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Hu, L., McArthur, C. and Jaffe, R.B. (2010): Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br. J. Cancer, <b>102<\/b>, 1276-1283.","DOI":"10.1038\/sj.bjc.6605626"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Keller, G. (2005): Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev., <b>19<\/b>, 1129-1155.","DOI":"10.1101\/gad.1303605"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Koppes, G.M. and Arnett, F.C. (1974): Salicylate hepatotoxicity. Postgrad. Med., <b>56<\/b>, 193-195.","DOI":"10.1080\/00325481.1974.11713882"},{"key":"27","first-page":"380","year":"2018","unstructured":"Kubara, K., Yamazaki, K., Ishihara, Y., Naruto, T., Lin, H.-T., Nishimura, K., Ohtaka, M., Nakanishi, M., Ito, M., Tsukahara, K., Morio, T., Takagi, M. and Otsu, M. (2018): Status of KRAS in iPSCs Impacts upon Self-Renewal and Differentiation Propensity. Stem Cell Reports, <b>11<\/b>, 380-394.","journal-title":"Stem Cell Reports","ISSN":"http:\/\/id.crossref.org\/issn\/2213-6711","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Kusakawa, S., Yamauchi, J., Miyamoto, Y., Sanbe, A. and Tanoue, A. (2008): Estimation of embryotoxic effect of fluoxetine using embryonic stem cell differentiation system. Life Sci., <b>83<\/b>, 871-877.","DOI":"10.1016\/j.lfs.2008.10.008"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Laschinski, G., Vogel, R. and Spielmann, H. (1991): Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to <i>in vitro<\/i> teratogenesis screening. Reprod. Toxicol., <b>5<\/b>, 57-64.","DOI":"10.1016\/0890-6238(91)90111-R"},{"key":"30","unstructured":"Li, D., Su, D., Xue, L., Liu, Y. and Pang, W. (2015): Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics. Int. J. Clin. Exp. Pathol., <b>8<\/b>, 11218-11223."},{"key":"31","doi-asserted-by":"publisher","unstructured":"Li, W., Wei, W., Zhu, S., Zhu, J., Shi, Y., Lin, T., Hao, E., Hayek, A., Deng, H. and Ding, S. (2009): Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell, <b>4<\/b>, 16-19.","DOI":"10.1016\/j.stem.2008.11.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Liu, H., Ren, C., Liu, W., Jiang, X., Wang, L., Zhu, B., Jia, W., Lin, J., Tan, J. and Liu, X. (2017a): Embryotoxicity estimation of commonly used compounds with embryonic stem cell test. Mol. Med. Rep., <b>16<\/b>, 263-271.","DOI":"10.3892\/mmr.2017.6552"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Liu, X., Nefzger, C.M., Rossello, F.J., Chen, J., Knaupp, A.S., Firas, J., Ford, E., Pflueger, J., Paynter, J.M., Chy, H.S., O\u2019Brien, C.M., Huang, C., Mishra, K., Hodgson-Garms, M., Jansz, N., Williams, S.M., Blewitt, M.E., Nilsson, S.K., Schittenhelm, R.B., Laslett, A.L., Lister, R. and Polo, J.M. (2017b): Comprehensive characterization of distinct states of human naive pluripotency generated by reprogramming. Nat. Methods, <b>14<\/b>, 1055-1062.","DOI":"10.1038\/nmeth.4436"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Luo, Y., Ellis, L.Z., Dallaglio, K., Takeda, M., Robinson, W.A., Robinson, S.E., Liu, W., Lewis, K.D., McCarter, M.D., Gonzalez, R., Norris, D.A., Roop, D.R., Spritz, R.A., Ahn, N.G. and Fujita, M. (2012): Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance. J. Invest. Dermatol., <b>132<\/b>, 2440-2450.","DOI":"10.1038\/jid.2012.161"},{"key":"35","doi-asserted-by":"crossref","unstructured":"MacDonagh, L., Gray, S.G., Breen, E., Cuffe, S., Finn, S.P., O\u2019Byrne, K.J. and Barr, M.P. (2016): Lung cancer stem cells: the root of resistance. Cancer Lett., <b>372<\/b>, 147-156.","DOI":"10.1016\/j.canlet.2016.01.012"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Martin, G.R. (1981): Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA, <b>78<\/b>, 7634-7638.","DOI":"10.1073\/pnas.78.12.7634"},{"key":"37","unstructured":"Narsinh, K.H., Plews, J. and Wu, J.C. (2011): Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? Mol. Ther., <b>19<\/b>, 635-638."},{"key":"38","doi-asserted-by":"crossref","unstructured":"Niess, H., Camaj, P., Renner, A., Ischenko, I., Zhao, Y., Krebs, S., Mysliwietz, J., J\u00e4ckel, C., Nelson, P.J., Blum, H., Jauch, K.W., Ellwart, J.W. and Bruns, C.J. (2015): Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis. Target. Oncol., <b>10<\/b>, 215-227.","DOI":"10.1007\/s11523-014-0323-z"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Ochiai, H., Suga, H., Yamada, T., Sakakibara, M., Kasai, T., Ozone, C., Ogawa, K., Goto, M., Banno, R., Tsunekawa, S., Sugimura, Y., Arima, H. and Oiso, Y. (2015): BMP4 and FGF strongly induce differentiation of mouse ES cells into oral ectoderm. Stem Cell Res. (Amst.), <b>15<\/b>, 290-298.","DOI":"10.1016\/j.scr.2015.06.011"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Onishi, K. and Zandstra, P.W. (2015): LIF signaling in stem cells and development. Development, <b>142<\/b>, 2230-2236.","DOI":"10.1242\/dev.117598"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Panova, A.V., Bogomazova, A.N., Lagarkova, M.A. and Kiselev, S.L. (2018): Epigenetic reprogramming by na\u00efve conditions establishes an irreversible state of partial X chromosome reactivation in female stem cells. Oncotarget, <b>9<\/b>, 25136-25147.","DOI":"10.18632\/oncotarget.25353"},{"key":"42","unstructured":"Park, T.S., Zimmerlin, L., Evans-Moses, R. and Zambidis, E.T. (2018): Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Na\u00efve-like State with Improved Multilineage Differentiation Potency. J. Vis. Exp., 57921."},{"key":"43","doi-asserted-by":"crossref","unstructured":"Qin, H., Hejna, M., Liu, Y., Percharde, M., Wossidlo, M., Blouin, L., Durruthy-Durruthy, J., Wong, P., Qi, Z., Yu, J., Qi, L.S., Sebastiano, V., Song, J.S. and Ramalho-Santos, M. (2016): YAP induces human naive pluripotency. Cell Rep., <b>14<\/b>, 2301-2312.","DOI":"10.1016\/j.celrep.2016.02.036"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Rich, R.R. and Johnson, J.S. (1973): Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis. Arthritis Rheum., <b>16<\/b>, 1-9.","DOI":"10.1002\/art.1780160102"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Ritz, C., Baty, F., Streibig, J.C. and Gerhard, D. (2015): Dose-Response Analysis Using R. PLoS One, <b>10<\/b>, e0146021.","DOI":"10.1371\/journal.pone.0146021"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Shen, D.W., Goldenberg, S., Pastan, I. and Gottesman, M.M. (2000): Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake. J. Cell. Physiol., <b>183<\/b>, 108-116.","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<108::AID-JCP13>3.0.CO;2-4"},{"key":"47","first-page":"663","year":"2006","unstructured":"Takahashi, K. and Yamanaka, S. (2006): Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, <b>126<\/b>, 663-676.","journal-title":"Cell","ISSN":"http:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"key":"48","doi-asserted-by":"publisher","unstructured":"Takashima, Y., Guo, G., Loos, R., Nichols, J., Ficz, G., Krueger, F., Oxley, D., Santos, F., Clarke, J., Mansfield, W., Reik, W., Bertone, P. and Smith, A. (2014): Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell, <b>158<\/b>, 1254-1269.","DOI":"10.1016\/j.cell.2014.08.029"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Tandon, S. and Jyoti, S. (2012): Embryonic stem cells: an alternative approach to developmental toxicity testing. J. Pharm. Bioallied Sci., <b>4<\/b>, 96-100.","DOI":"10.4103\/0975-7406.94808"},{"key":"50","first-page":"196","year":"2007","unstructured":"Tesar, P.J., Chenoweth, J.G., Brook, F.A., Davies, T.J., Evans, E.P., Mack, D.L., Gardner, R.L. and McKay, R.D. (2007): New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature, <b>448<\/b>, 196-199.","journal-title":"?Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"51","first-page":"471","year":"2014","unstructured":"Theunissen, T.W., Powell, B.E., Wang, H., Mitalipova, M., Faddah, D.A., Reddy, J., Fan, Z.P., Maetzel, D., Ganz, K., Shi, L., Lungjangwa, T., Imsoonthornruksa, S., Stelzer, Y., Rangarajan, S., D\u2019Alessio, A., Zhang, J., Gao, Q., Dawlaty, M.M., Young, R.A., Gray, N.S. and Jaenisch, R. (2014): Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell, <b>15<\/b>, 471-487.","journal-title":"Cell Stem Cell","ISSN":"http:\/\/id.crossref.org\/issn\/1934-5909","issn-type":"print"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Tsunekuni, K., Konno, M., Haraguchi, N., Koseki, J., Asai, A., Matsuoka, K., Kobunai, T., Takechi, T., Doki, Y., Mori, M. and Ishii, H. (2019): CD44\/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure. Sci. Rep., <b>9<\/b>, 14861.","DOI":"10.1038\/s41598-019-50968-6"},{"key":"53","doi-asserted-by":"publisher","unstructured":"Valamehr, B., Robinson, M., Abujarour, R., Rezner, B., Vranceanu, F., Le, T., Medcalf, A., Lee, T.T., Fitch, M., Robbins, D. and Flynn, P. (2014): Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Reports, <b>2<\/b>, 366-381.","DOI":"10.1016\/j.stemcr.2014.01.014"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Wang, W., Yang, J., Liu, H., Lu, D., Chen, X., Zenonos, Z., Campos, L.S., Rad, R., Guo, G., Zhang, S., Bradley, A. and Liu, P. (2011): Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc. Natl. Acad. Sci. USA, <b>108<\/b>, 18283-18288.","DOI":"10.1073\/pnas.1100893108"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Ware, C.B., Nelson, A.M., Mecham, B., Hesson, J., Zhou, W., Jonlin, E.C., Jimenez-Caliani, A.J., Deng, X., Cavanaugh, C., Cook, S., Tesar, P.J., Okada, J., Margaretha, L., Sperber, H., Choi, M., Blau, C.A., Treuting, P.M., Hawkins, R.D., Cirulli, V. and Ruohola-Baker, H. (2014): Derivation of naive human embryonic stem cells. Proc. Natl. Acad. Sci. USA, <b>111<\/b>, 4484-4489.","DOI":"10.1073\/pnas.1319738111"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Warrier, S., Popovic, M., Van der Jeught, M. and Heindryckx, B. (2016): Establishment and characterization of na\u00efve pluripotency in human embryonic stem cells. Methods Mol. Biol., <b>1516<\/b>, 13-46.","DOI":"10.1007\/7651_2016_347"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Warrier, S., Van der Jeught, M., Duggal, G., Tilleman, L., Sutherland, E., Taelman, J., Popovic, M., Lierman, S., Chuva De Sousa Lopes, S., Van Soom, A., Peelman, L., Van Nieuwerburgh, F., De Coninck, D.I., Menten, B., Mestdagh, P., Van de Sompele, J., Deforce, D., De Sutter, P. and Heindryckx, B. (2017): Direct comparison of distinct naive pluripotent states in human embryonic stem cells. Nat. Commun., <b>8<\/b>, 15055.","DOI":"10.1038\/ncomms15055"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Wouters, J., Stas, M., Gremeaux, L., Govaere, O., Van den Broeck, A., Maes, H., Agostinis, P., Roskams, T., van den Oord, J.J. and Vankelecom, H. (2013): The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis. PLoS One, <b>8<\/b>, e76550.","DOI":"10.1371\/journal.pone.0076550"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Yamane, J., Aburatani, S., Imanishi, S., Akanuma, H., Nagano, R., Kato, T., Sone, H., Ohsako, S. and Fujibuchi, W. (2016): Prediction of developmental chemical toxicity based on gene networks of human embryonic stem cells. Nucleic Acids Res., <b>44<\/b>, 5515-5528.","DOI":"10.1093\/nar\/gkw450"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Yeh, C.-T., Wu, A.T., Chang, P.M., Chen, K.-Y., Yang, C.-N., Yang, S.C., Ho, C.C., Chen, C.C., Kuo, Y.L., Lee, P.Y., Liu, Y.W., Yen, C.C., Hsiao, M., Lu, P.J., Lai, J.M., Wang, L.S., Wu, C.H., Chiou, J.F., Yang, P.C. and Huang, C.Y. (2012): Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. Am. J. Respir. Crit. Care Med., <b>186<\/b>, 1180-1188.","DOI":"10.1164\/rccm.201207-1180OC"},{"key":"61","first-page":"881","year":"1996","unstructured":"Yeom, Y.I., Fuhrmann, G., Ovitt, C.E., Brehm, A., Ohbo, K., Gross, M., H\u00fcbner, K. and Sch\u00f6ler, H.R. (1996): Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development, <b>122<\/b>, 881-894.","journal-title":"Development","ISSN":"http:\/\/id.crossref.org\/issn\/0950-1991","issn-type":"print"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Xia, L., Wang, H., Oyang, L., Su, M., Liu, Q., Lin, J., Tan, S., Tian, Y., Liao, Q. and Cao, D. (2018): Cancer stem cells in progression of colorectal cancer. Oncotarget, <b>9<\/b>, 33403-33415.","DOI":"10.18632\/oncotarget.23607"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Zimmerlin, L., Park, T.S., Huo, J.S., Verma, K., Pather, S.R., Talbot, C.C. Jr., Agarwal, J., Steppan, D., Zhang, Y.W., Considine, M., Guo, H., Zhong, X., Gutierrez, C., Cope, L., Canto-Soler, M.V., Friedman, A.D., Baylin, S.B. and Zambidis, E.T. (2016): Tankyrase inhibition promotes a stable human na\u00efve pluripotent state with improved functionality. Development, <b>143<\/b>, 4368-4380.","DOI":"10.1242\/dev.138982"},{"key":"64","unstructured":"No authors listed (1973): Liver injury by salicylates. Br. Med. J., <b>2<\/b>, 732."}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/46\/3\/46_131\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T03:41:55Z","timestamp":1615002115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/46\/3\/46_131\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.46.131","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}